| Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised … B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ... The Lancet 394 (10212), 1915-1928, 2019 | 2262 | 2019 |
| Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised … RJ Motzer, BI Rini, DF McDermott, OA Frontera, HJ Hammers, ... The Lancet Oncology 20 (10), 1370-1385, 2019 | 707 | 2019 |
| 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer F Bensch, EL van der Veen, MN Lub-de Hooge, A Jorritsma-Smit, ... Nature medicine 24 (12), 1852-1858, 2018 | 572 | 2018 |
| Prognostic versus predictive value of biomarkers in oncology C Oldenhuis, SF Oosting, JA Gietema, EGE De Vries European journal of cancer 44 (7), 946-953, 2008 | 452 | 2008 |
| The metabolic syndrome in cancer survivors EC De Haas, SF Oosting, JD Lefrandt, BHR Wolffenbuttel, DT Sleijfer, ... The lancet oncology 11 (2), 193-203, 2010 | 256 | 2010 |
| mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ... The Lancet Oncology 22 (12), 1681-1691, 2021 | 147 | 2021 |
| VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment WB Nagengast, MN Lub-de Hooge, SF Oosting, WFA den Dunnen, ... Cancer research 71 (1), 143-153, 2011 | 141 | 2011 |
| 89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment SF Oosting, AH Brouwers, SC van Es, WB Nagengast, THO Munnink, ... Journal of Nuclear Medicine 56 (1), 63-69, 2015 | 139 | 2015 |
| Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake M Arjaans, TH Oude Munnink, SF Oosting, ... Cancer research 73 (11), 3347-3355, 2013 | 136 | 2013 |
| VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside M Arjaans, CP Schröder, SF Oosting, U Dafni, JE Kleibeuker, ... Oncotarget 7 (16), 21247, 2016 | 125 | 2016 |
| Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations AL Ho, I Brana, R Haddad, J Bauman, K Bible, S Oosting, DJ Wong, ... Journal of Clinical Oncology 39 (17), 1856, 2021 | 121 | 2021 |
| Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck … K Wopken, HP Bijl, A van der Schaaf, HP van der Laan, O Chouvalova, ... Radiotherapy and Oncology 113 (1), 95-101, 2014 | 119 | 2014 |
| Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands E Boon, W van Boxtel, J Buter, RJ Baatenburg de Jong, RJJ van Es, M Bel, ... Head & neck 40 (3), 605-613, 2018 | 117 | 2018 |
| A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model MJ Boomsma, HP Bijl, MEMC Christianen, I Beetz, O Chouvalova, ... International Journal of Radiation Oncology* Biology* Physics 84 (3), e351-e356, 2012 | 115 | 2012 |
| Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia HP van der Laan, HP Bijl, RJHM Steenbakkers, A van der Schaaf, ... Radiotherapy and Oncology 115 (1), 56-62, 2015 | 106 | 2015 |
| A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from T he N etherlands E Boon, M Bel, W van Boxtel, WTA van der Graaf, RJJ van Es, ... International journal of cancer 143 (4), 758-766, 2018 | 101 | 2018 |
| Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation MEMC Christianen, IM Verdonck-de Leeuw, P Doornaert, O Chouvalova, ... Radiotherapy and Oncology 117 (1), 139-144, 2015 | 101 | 2015 |
| Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib‐Induced Hypertension K Eechoute, AAM Van Der Veldt, S Oosting, MHW Kappers, JAM Wessels, ... Clinical Pharmacology & Therapeutics 92 (4), 503-510, 2012 | 100 | 2012 |
| Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy MI van Rijn-Dekker, L van den Bosch, JGM van den Hoek, HP Bijl, ... Radiotherapy and Oncology 147, 103-110, 2020 | 97 | 2020 |
| Everolimus reduces 89Zr-bevacizumab tumor uptake in patients with neuroendocrine tumors SJ van Asselt, SF Oosting, AH Brouwers, AHH Bongaerts, JR de Jong, ... Journal of Nuclear Medicine 55 (7), 1087-1092, 2014 | 90 | 2014 |
